Verastem
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 73
- Market Cap
- -
- Website
- http://www.verastem.com
- Introduction
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Verastem, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01778803
- Locations
- 🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸University of Oklahoma, Oklahoma City, Oklahoma, United States
🇺🇸Sarah Cannon Research Institute, Nashville, Tennessee, United States
A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- Verastem, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT00787033
- Locations
- 🇨🇦
Pfizer Investigational Site, Toronto, Ontario, Canada
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
Phase 1
Completed
- Conditions
- Head and Neck NeoplasmProstatic NeoplasmPancreatic Neoplasm
- Interventions
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2013-03-21
- Lead Sponsor
- Verastem, Inc.
- Target Recruit Count
- 99
- Registration Number
- NCT00666926
- Locations
- 🇨🇦
Pfizer Investigational Site, Toronto, Ontario, Canada